Scisparc announces enrollment of the first five patients in the clinical trial of its innovative sci-210 treatment

The clinical trial for sci-210 is conducted in israel, after which the company aims to move forward with the commercialization process of sci-210, first in the israeli market

SPRC Ratings Summary

SPRC Quant Ranking